States / New Hampshire / SB 465

SB 465 Failed

classifying xylazine as a schedule III controlled drug.

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted

Version comparison

2 versions

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.